TAFA4-IL-10 axis potentiate immunotherapy for airway allergy by induction of specific regulatory T cells

Allergen-specific immunotherapy (AIT) is the main treatment for allergic diseases. The therapeutic efficacy of AIT has to be improved. Neuropeptides, such as TAFA4, have immune-regulating features. The objective of this study is to promote the efficacy of AIT in experimental allergic rhinitis (AR) b...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Shuyao, Luo, Xiangqian, Mo, Lihua, Zhang, Shuang, Liao, Yun, Guan, Li, Yang, Liteng, Huang, Qinmiao, Liu, Dabo, Yang, Pingchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622679/
https://www.ncbi.nlm.nih.gov/pubmed/36316414
http://dx.doi.org/10.1038/s41541-022-00559-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622679/
https://www.ncbi.nlm.nih.gov/pubmed/36316414
http://dx.doi.org/10.1038/s41541-022-00559-w

Ejemplares similares